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Abstract
Background: There is a paucity of tools that can be used in routine clinical practice to assess the psychosocial
impact of Disorders/Differences of Sex Development (DSD) on parents and children.
Objective: To evaluate the use of short Parent Self-Report and Parent Proxy-Report questionnaires that can be used
in the outpatient setting.
Methods: Previously validated DSD-specific and generic items were combined to develop a Parent Self-Report
questionnaire and a Parent Proxy-Report questionnaire for children under 7 years. Of 111 children approached at
one tertiary paediatric hospital, the parents of 95 children (86%) with DSD or other Endocrine conditions completed
these questionnaires.
Results: Questionnaires took under 10 min to complete and were found to be easy to understand. Compared to
reference, fathers of children with DSD reported less stress associated with Clinic Visits (p = 0.02) and managing
their child’s Medication (p = 0.04). However, parents of children with either DSD or other Endocrine conditions
reported more symptoms of Depression (p = 0.03). Mothers of children with DSD reported greater Future Concerns
in relation to their child’s condition (median SDS − 0.28; range − 2.14, 1.73) than mothers of children with other
Endocrine conditions (SDS 1.17; − 2.00, 1.73) (p = 0.02). Similarly, fathers of children with DSD expressed greater
Future Concerns (median SDS -1.60; − 4.21, 1.00) than fathers of children with other Endocrine conditions (SDS 0.48;
− 2.13, 1.52) (p = 0.04).
Conclusion: DSD was associated with greater parental concerns over the child’s future than other Endocrine
conditions. Brief parent-report tools in DSD can be routinely used in the outpatient setting to assess and monitor
parent and patient needs.
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Introduction
Conditions that affect somatic sex development such as
Differences/Disorders of Sex Development (DSD) can
impose a high degree of stress on patients and their fam-
ilies and exert a wide range of effects on ‘social and psy-
chosexual adjustment, mental health, quality of life and
social participation’ [1–3]. Distress related to shame and
‘stigma’ associated with DSD, uncertainties regarding
diagnosis and limited coping strategies may lead to an
increased risk of adverse psychosocial outcomes dispro-
portionate to the severity of the DSD [4–7]. A significant
minority of parents of children with DSD experience
symptoms suggestive of post-traumatic stress disorder
with accompanying difficulties in communicating news
of their child’s condition with relatives and close friends,
an independent risk factor for emotional distress [8, 9].
Yet there is a paucity of studies evaluating the feasibility
of routine, longitudinal screening for challenges to
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positive psychosocial adaptation in the context of usual
care [10–12]. Such screening would ideally go beyond
the heretofore restricted focus on psychosexual differen-
tiation, i.e., gender identity, gender role, and sexual
orientation [11, 13].
Generally, there has been growing interest in adopting
standardised tools for assessing subjective experiences of
patients and incorporating reports of parent/caregiver
proxies in young children in the context of ongoing pa-
tient care [14, 15]. The assessment of a child’s adapta-
tion to their medical condition is also becoming
increasingly common [16] with the use of parent-proxy
reporting playing an important role in overcoming chal-
lenges associated with assessing the subjective experi-
ence of young children [17]. Parent/patient reported
outcome (PRO) measures can be generic (i.e., applicable
to all populations), such as the scales comprising the ‘Pa-
tient-Reported Outcomes Measurement Information
System’ (PROMIS®) [18] and the ‘Patient Health Ques-
tionnaire for Depression and Anxiety’ [19] or can be
condition-specific, for example, the ‘Pediatric Asthma
Scale’ [20]. A methodological gap in developing such
tools was recently addressed by the development of
DSD-specific health-related quality of life measures for
parents of children under 7 years of age including a
parent-proxy measure and a self-report measure [4].
Whereas these tools were developed for use within
multidisciplinary DSD clinics with dedicated behavioural
health specialists, it is unclear whether their use would
be feasible in settings with more limited staffing and
time constraints. There is a need to explore tools that
can overcome the perceived challenges of managing pa-
tients in a busy clinic setting and have maximum accept-
ability by parents and professionals [21, 22].
The purpose of this project was to develop a self-
report questionnaire for parents of children aged from
birth to under 7 years and a parallel proxy-report ques-
tionnaire for parents of children aged 2 to < 7 years,
using existing validated DSD-specific [4, 5] and generic
items [18], for parents of young children, that can be
routinely used in a busy outpatient setting to assess the
impact of DSD on parents and their children.
Methods
Parents
Parents of children under the age of 7 years attending
DSD and Endocrine outpatient clinics at one specialist
paediatric centre, were approached between February
2017 and February 2019 (Fig. 1). Exclusion criteria in-
cluded the need for an interpreter for questionnaire
completion, thus, parental eligibility was restricted to
those whose primary language was English. Parents were
approached at the end of clinic consultations, advised
verbally and provided with a cover note that their
participation was optional and that the completed ques-
tionnaires would be included in their child’s health rec-
ord as part of routine clinical care. Questionnaires were
provided to one parent/carer attending clinic with their
child with the exception of four cases for whom both
mothers and fathers completed questionnaires. Only two
of the respondents who completed the questionnaires
were not biological parents of the children, but all were
referred to as ‘mothers’ and ‘fathers’. All parents
returned completed questionnaires prior to leaving the
clinic. A section at the end of the questionnaire sought
parental feedback on simplicity of the questionnaire, on
acceptability of the length of time for completion and on
comprehension of questions. The questionnaire was ap-
proved by the research ethics office as part of routine
healthcare evaluation. The completed questionnaires
were available to the DSD multidisciplinary team asses-
sing care and for discussion at subsequent pre-clinic
meetings for evaluation of ongoing care.
Parent self-report (PSR) questionnaire
The 40-item PSR (Additional file 1: Table S1, Additional
file 1: Figure S1) was developed for parents of children aged
from birth to < 7 years to assess parental feelings and expe-
riences in relation to their child’s condition (DSD or other
Endocrine conditions). The PSR is comprised of 8 domains
(Healthcare Communication and Information, Talking to
Others, Future Concerns, Medication, Clinic Visit, Surgery,
Stigma, and Anxiety/Depression) selected from the previ-
ously validated Quality of Life DSD Parent (QOL-DSD-Par-
ent) report [4], parent-focused items of the Experiences and
Reactions questionnaire assessing DSD-related experienced
or anticipated stigma [5], and the Patient Health
Questionnaire-4 (PHQ-4) [19], a screening scale for depres-
sion and anxiety (Table 1).
Parent proxy-report (PPR) questionnaire
The 30-item PPR (Additional file 1: Table S2, Additional
file 1: Figure S2) was developed for parents of children
aged 2 to < 7 years to capture their perceptions of the
child’s feelings and experiences related to their condition
(DSD or other Endocrine condition). Paralleling con-
struction of the PSR, the PPR comprises 8 domains
(Anxiety, Depression, Anger, Peer Relationships, Stigma,
Clinic Visits, Medications, and Missed School Days) se-
lected from the Quality of Life DSD Proxy (QOL-DSD-
Proxy) report [4], child-focused items of the Experiences
and Reactions questionnaire [5] and select PROMIS
Parent-Proxy scales [18] (Table 1).
Questionnaire scoring
DSD reference data were obtained from a previous study
validating DSD-specific, parent-reported, health-related
quality of life measures for children under the age of 7
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years [4]. For both PSR and PPR questionnaires, parents
rated their experiences/perceptions on 5-point Likert
scales (Additional file 1: Tables S1 and S2). For each do-
main, a scale average was obtained if at least half of the
items were completed, and this was incorporated into the
calculation of the median standard deviation score (SDS).
Responses were standardised from 0 to 100, with higher
scores in the majority of domains indicating better quality
of life and more positive adaptation (Table 1). The Experi-
ences and Reactions (Stigma) domain [5] was also scored
on 5-point scale, with higher scores indicating a greater
level of experienced (or anticipated) stigma. Median SDS,
i.e., the number of SDs away from the mean, for question-
naire domains stemming from the QOL-DSD-Parent,
QOL-DSD-Proxy reports [4] and the Experiences and Re-
action (Parent-Focused and Child-Focused) questionnaire
[5], were calculated using separate mother and father
means and SDs obtained from reference data (Table 1).
Total scores for the PHQ-4 screening scale [19] for de-
pression and anxiety were categorized as normal (0–2),
mild (3–5), moderate (6–8), and severe (9–12). On each
subscale, a score of 3 or greater was considered positive
for screening purposes. As per recommended scoring pro-
cedures [23–26], PROMIS® raw scale scores for Anxiety,
Depression, Anger and Peer Relationships were converted
to standardized “T scores” (mean 50; SD 10) employing
the Health Measures Scoring ServiceSM [27] which utilizes
norms for healthy 5 to 17-year children in the U.S. general
population as the referent sample. For Anxiety, Depres-
sion and Anger, a higher score, for example T = 60, was
representative of a + 1SD elevation in symptoms relative
to the normative sample [23–25]. In the case of Peer Rela-
tionships, T = 60 reflected better social interactions by the
same +1SD [26].
Fig. 1 Cases and recruitment details. DSD, Disorder of Sex Development. aCaregivers not approached due to consultation running simultaneously
(n = 7) bCaregivers not able to complete questionnaires as insufficient time after clinic (n = 8), other commitments (n = 7) or already completed a
separate hospital questionnaire (n = 1)
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Statistical analysis
Data analysis was performed using Minitab version 18
statistical software (Minitab LLC, State College, PA,
USA). All data were described as medians and ranges
(minimum, maximum); comparison between groups
was performed by the Kruskal-Wallis test for continu-
ous variables and subsequently adjusted for multiple
comparisons using false discovery rates [28]. For
DSD-specific and generic domains, the mean (SD) de-
rived from previously validated reference data was
used in the calculation of median SDS for each do-
main (Table 1). For DSD-specific domains, the me-
dian SDS of mothers and fathers within DSD and
Endocrine groups were analysed to enable cross-
parent comparisons. For all domains within both
questionnaires, the median SDS of the DSD group
was compared to the median SDS of the Endocrine
group and the median SDS of each group (DSD and
Endocrine) was also compared to SDS of zero.
Mothers and fathers scores were combined for the
PROMIS® measures as per scoring guidelines. A p
value of less than 0.05 was considered statistically
significant.
Results
Characteristics of DSD cases
For the Parent Self-Report (PSR) questionnaire, data were
available for 55 parents (42 mothers and 13 fathers) of 54
children and for the Parent Proxy-Report (PPR) question-
naire, data were available for 25 parents (18 mothers and
7 fathers) of 25 children (Table 2). The median age of the
54 children for whom PSR questionnaires were completed
was 1.8 years (range 0.03, 6.8 years) and of these, 44 (82%)
were reared as boys. The median age of the 25 children
for whom PPR questionnaires were completed was 4.5
years (2.0, 6.65) and of these, 16 (64%) were boys.
Amongst the 54 DSD cases, 40 (74%) had 46, XY DSD
with 28 (51%) having a diagnosis of a non-specific DSD
(e.g. bilateral cryptorchidism or proximal hypospadias).
Sex chromosome DSD and 46, XX DSD accounted for 7
(13%) cases each. Of the 54 cases, 16 (30%) had other con-
ditions including cardiorespiratory disease, non-sex
chromosome abnormalities or developmental delay.
Characteristics of endocrine cases
For the PSR questionnaire, data were available for 43
parents (34 mothers and 9 fathers) of 41 children and
Table 1 PRO questionnaire domains, score representation and reference mean (SD)
Questionnaire
Domains
Items Domains
derived from:
High subscale scores indicate: Sample mean (SD) from reference
samplea,b
Reference
sample
Mothers Fathers Sample- All
Parent Self-Report
Communication
and Information
2 QOL-DSD Better outcome 74.86 (16.93) 69.97 (23.15) – Alpern et al.
(2017)4
Talking to Others 5 QOL-DSD Better outcome 64.03 (24.52) 85.55 (16.80) –
Future Concerns 7 QOL-DSD Better outcome 55.37 (25.86) 79.14 (13.71) –
Medication 4 QOL-DSD Better outcome 70.39 (28.20) 49.10 (28.31) –
Clinic Visit 4 QOL-DSD Better outcome 72.08 (27.81) 33.38 (25.80) –
Surgery 4 QOL-DSD Better outcome 38.03 (25.12) 81.10 (24.51) –
Stigma 10 Experiences & Reactions:
Parent focused
Poorer outcome 1.76 (0.63) 1.56 (0.44) – Rolston et al.
(2015)5
PHQ-4 4 Patient Health
Questionnaire-4
Poorer outcome – – 2.5 (2.8) Kroenke et al.
(2009)19
Parent Proxy-Report
Anxiety 4 PROMIS Poorer outcome – – 50 (10) Irwin et al.,
(2012)18
Depression 4 PROMIS Poorer outcome – – 50 (10)
Anger 5 PROMIS Poorer outcome – – 50 (10)
Peer Relations 4 PROMIS Better outcome – – 50 (10)
Stigma 4 Experiences &
Reactions: Child
focused
Poorer outcome 2.28 (0.91) 2.05 (0.81) – Rolston et al.
(2015)5
Clinic Visit &
Medication
7
1
QOL-DSD Better outcome 64.98 (24.49) 78.10 (22.56) – Alpern et al.
(2017)4
aSample mean (SD) from reference data was used to calculate median SDS for each domain [4, 5, 18, 19]. bMean (SD) represents the mean (SD) T score for
PROMIS domains
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Table 2 Sample characteristics of children with DSD and other Endocrine diagnoses
DSD sample Parental Questionnaire
Self-Reporta Proxy-Reportb
Index cases (n) 54 25
Parents (n)c 55 25
Mother 42 18
Father 13 7
Child gender (n, %)
Male 44 (81.5%) 16 (64.0%)
Female 10 (18.5%) 9 (36.0%)
Child age, years (median, range) 1.8 (0.03, 6.8) 4.5 (2.0, 6.5)
DSD category and diagnosis
Sex chromosome (n, %) 7 (13.0%) 6 (24.0%)
Turner syndrome 4 (7.4%) 4 (16.0%)
Other sex chromosome DSD (e.g. Klinefelter syndrome, 45X/46Y primary gonadal
dysgenesis, XO/X isodicentric Y chromosome complement)
3 (5.5%) 2 (8.0%)
46, XX (n, %) 7 (13.0%) 6 (24.0%)
Disorder of androgen excess (congenital adrenal hyperplasia) 6 (11.1%) 5 (20.0%)
Other 46, XX DSD (e.g. vaginal atresia) 1 (1.9%) 1 (4.0%)
46, XY (n, %) 40 (74.0%) 13 (52.0%)
Disorder of gonadal (testicular) development (e.g. bilateral anorchia) 1 (1.9%) 1 (4.0%)
Non-specific disorder of undermasculinisation (e.g. bilateral cryptorchidism,
isolated hypospadias)
28 (51.2%) 9 (36.0%)
Other 46, XY DSD (e.g. combination of hypospadias and bilateral cryptorchidism
or micropenis)
11 (20.4%) 3 (12.0%)
Endocrine sample
Index cases (n) 41 22
Parents (n)d 43 23
Mother 34 17
Father 9 6
Child gender (n, %)
Male 23 (56.1%) 13 (59%)
Female 18 (43.9%) 9 (40.9%)
Child age, years (median, range) 2.0 (0.1, 6.8) 5.0 (2.3, 6.9)
Endocrine category (n, %)
Disorders of short stature or growth hormone deficiency 14 (34%) 11 (50.0%)
Disorder of calcium and phosphate homeostasis 11 (26.9%) 4 (18.1%)
Disorder of thyroid gland 7 (17.1%) 4 (18.1%)
Disorder of adrenal gland 3 (7.3%) 2 (9.1%)
Disorder of pituitary gland 2 (4.9%) 0
Genetic disorders of glucose and insulin homeostasis 2 (4.9%) 0
Other (e.g. primary polydipsia, premature tooth exfoliation) 2 (4.9%) 1 (4.5%)
aParent Self-Report (PSR) questionnaire completed by parents of children from birth to 2 years. bParent Proxy-Report (PPR) questionnaire completed by parents of
children aged 2 to 6 years
cFor one child, both parents completed PSR
dFor two children, both parents completed PSR and for one child, both parents completed PPR
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for the PPR questionnaire, data were available for 23
parents (17 mothers and 6 fathers) of 22 children
(Table 2). The median age of the 41 children for whom
parents completed PSR questionnaires was 2.0 years (0.1,
6.8) and of these 41 children, 23 (56%) were raised as
boys. The median age of the 22 children for whom PPR
questionnaires were available was 5.0 years (2.3, 6.9) and
of these, 13 (59%) were boys. The most frequent endo-
crine diagnoses amongst the 41 children who had PSR
questionnaires were conditions associated with short
stature or growth hormone deficiency in 14 (34%) chil-
dren and disorders of bone metabolism in 11 (27%) chil-
dren. In the 22 children who had PPR questionnaires
completed, these two diagnoses were present in 11
(50%) and 4 (18%) children, respectively. Other endo-
crine diagnoses in cases for whom PSR and PPR ques-
tionnaires were completed included thyroid disease (n =
7; n = 4), adrenal insufficiency (n = 3; n = 2), septo-optic
dysplasia (n = 2), hyperinsulinism (n = 2), primary poly-
dipsia (n = 1) and premature tooth exfoliation (n = 1);
these diagnoses accounted for less than 7% of conditions
amongst the endocrine cases. Of the 41 endocrine cases,
17 (41%), had other co-morbidity including cardiac, re-
spiratory or neurological problems.
Parent self-report scores - comparison to reference
Fathers of children with DSD had lower median SDS for
Future Concerns [SDS -1.60 (− 4.21, 1.00); p = 0.02], indi-
cating greater apprehension, compared to reference data
(Table 3, Fig. 2). However, these fathers had a higher me-
dian SDS for Medication [SDS 1.80 (1.01, 1.80); p = 0.04]
and Clinic Visits [SDS 2.10 (0.16, 2.58); p = 0.02], indicat-
ing lesser degrees of stress relating to their child’s medica-
tion regimen and clinic visits. Mothers of children with
other Endocrine conditions had a higher median SDS for
Talking to Others [SDS 0.78 (− 0.83, 1.47); p = 0.02], Fu-
ture Concerns [SDS 1.17 (− 2.00, 1.73); p = 0.02) and
Clinic Visits [SDS 0.70 (− 1.37, 0.99); p = 0.02], indicative
of less concerns in each of these domains. Fathers of chil-
dren with other Endocrine conditions also had a higher
SDS for Clinic Visits [SDS 1.37 (0.64, 2.60); p = 0.04], indi-
cating less stress associated with clinic attendances, com-
pared to reference data.
Parent self-report scores – comparison between DSD and
endocrine groups
Mothers of children with DSD had lower median SDS
for Future Concerns, indicating a greater level of con-
cerns, than mothers of children with other Endocrine
conditions [SDS -0.28 (− 2.14, 1.73) vs SDS 1.17 (− 2.00,
7.73); p = 0.02] (Table 3, Fig. 2). Similarly, fathers of chil-
dren with DSD had a lower median SDS for Future Con-
cerns compared with fathers of children with other
Endocrine conditions [SDS -1.60 (− 4.21, 1.00) vs SDS
0.48 (− 2.13, 1.52); p = 0.04] indicating greater concerns
in fathers of children with DSD. For both DSD and
Endocrine groups, median PHQ-4 scores were not in the
range associated with clinically significant symptomology
and there was no significant difference in PHQ-4 scores
between mothers and fathers of children with DSD com-
pared with mothers and fathers of children with other
Endocrine conditions (p > 0.05).
Parent proxy-report scores- comparison to reference
Parents of children with DSD had higher median SDS
for Depression [SDS 1.28 (− 1.52, 1.28); p = 0.03] indica-
tive of greater depressive symptoms, compared to refer-
ence data (Table 4). Similarly, parents of children with
other Endocrine conditions reported more symptoms of
Depression [SDS 0.64 (− 1.01, 1.28); p = 0.03]. There was
no significant difference in other Proxy-Report domains
(including Anxiety, Anger and Peer Relations, Stigma,
Clinic Visits and Medication) between parents of chil-
dren with DSD or other Endocrine conditions, compared
to reference data.
Parent proxy-report scores- comparison between DSD
and endocrine groups
There was no significant difference in the PROMIS®
scores for Anxiety, Depression, Anger and Peer Relation-
ships between parents of children with DSD and parents
of children with other Endocrine conditions (Table 4).
In addition, there were no differences between parents
of children with DSD compared with other Endocrine
conditions with regards to DSD-specific domains includ-
ing Stigma, Clinic Visits or Medications. Parents of chil-
dren with DSD reported a median of 0 Missed School
Days (0.0, 3.0) over the previous 6-month period com-
pared to 0.5 days (0.0, 5.0) for children with other Endo-
crine conditions.
Questionnaire acceptability
Of the 111 children whose parents were approached, the
parents of 95 children with DSD or other Endocrine
conditions completed the questionnaires (86%).In all
cases, parents completed the questionnaires in less than
10min and all parents reported that the questionnaire
was acceptable for the time it took to complete the ques-
tionnaire, and questions were ‘easy to understand’ and
‘easy to follow’.
Discussion
This is the first report of the use of brief patient-
centered and parent-reported outcome tools, in parents
and young children with DSD and a range of other
Endocrine conditions that can be completed in less than
10min as part of routine health care. It has demon-
strated that parent self-report and parent proxy-report
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questionnaires are an acceptable practice in this context
and can be routinely used in the outpatient setting to as-
sess and monitor parent and patient needs. The rationale
guiding the selection of the psychosocial domains to be in-
cluded within our questionnaires was the same as that
used for psychosocial assessments within the DSD-
Translational Research Network [21] (i.e., that the mea-
sures deliver actionable information for the individual pa-
tient/family), with an additional requirement of reducing
the time for questionnaire completion. The purpose of
our assessment tools was to proactively monitor both pa-
tient and family psychosocial adaptation at a specific point
in time enabling rapid quantification and insight into the
experiences of children with DSD and other Endocrine
conditions. Although the assessment approach adopted in
selecting questionnaire items to characterize the adapta-
tion of parents and young children with these chronic
medical conditions was largely “non-categorical” [29], the
finalized questionnaires included items that focussed on
issues specific to, and shared by young patients born with
DSD, and their families, that are not otherwise covered by
generic health-related quality of life measures.
In the current report, questionnaires were introduced
to patients following the clinic consultation; however,
pre-clinic questionnaire completion and scoring would
enable clinicians to review and act on results at the time
of clinic visits and would increase their clinical utility. A
quicker and simpler way of instantaneously displaying
the results in the clinic setting could also increase the
acceptability as well as the implementation of the tool
[30]. The current report relates to evaluation of cross-
sectional data from questionnaires collected from a large
group of cases with a wide range of conditions within
the umbrella of DSD. As a larger sample of cases with
greater diagnostic homogeneity is collected with time,
construct validity could be tested to determine the ex-
tent to which the questionnaires discrimate between
groups that are known to differ on the items of interest.
Table 3 Parent Self-Report questionnaire scores for children with DSD and children with other Endocrine conditions
Self-
Report
Domains
DSD Sample Endocrine Sample DSD vs Endocrine
na Subscale score,
median (range)
SDSb, median (range) na Subscale score,
median (range)
SDSb, median (range) p valuec
Communication and Information
Mothers 42 75.00 (37.50, 100.00) 0.01 (−2.21, 1.49) 34 75.00 (25.00, 100.00) 0.01 (−2.95, 1.49) NS
Fathers 13 75.00 (37.50, 87.50) 0.22 (−1.40, 0.76) 9 62.5 (0.00, 87.50) −0.32 (−3.02, 0.76) NS
Talking to Others
Mothers 41 62.50 (35.00, 100.00) −0.06 (− 1.18, 1.47) 34 83.13 (43.75, 100.00) 0.78* (− 0.83, 1.47) NS
Fathers 12 81.25 (37.50, 100.00) −0.25 (−2.86, 0.86) 9 90.00 (45.00, 100.00) 0.27 (−2.41, 0.86) NS
Future Concerns
Mothers 42 50.00 (0.00, 100.00) −0.28 (−2.14, 1.73) 35 85.71 (3.57, 100.00) 1.17* (−2.00, 1.73) 0.02
Fathers 13 57.14 (21.43, 92.86) −1.60* (−4.21, 1.00) 9 85.71 (50.00, 100.00) 0.48 (− 2.13, 1.52) 0.04
Medication
Mothers 14 66.67 (0.00, 100.00) −0.13 (−2.50, 1.05) 25 83.33 (0.00, 100.00) 0.31 (−2.50, 1.05) NS
Fathers 6 100.00 (77.78, 100.00) 1.80* (1.01, 1.80) 3 100.00 (75.00, 100.00) 1.80 (0.92, 1.80) NS
Clinic Visit
Mothers 38 70.83 (56.25, 100.00) −0.05 (−1.69, 1.00) 32 91.67 (33.33, 100.00) 0.70* (−1.37, 0.99) NS
Fathers 11 87.50 (37.50, 100.00) 2.10* (0.16, 2.58) 8 68.75 (50.00, 91.67) 1.37* (0.64, 2.60) NS
Surgery
Mothers 11 12.50 (0.00, 91.67) −1.02 (−1.51, 2.14) 4 31.30 (0.00, 83.30) 0.47 (−1.02, 1.80) NS
Fathers 4 41.70 (25.0, 100.00) −1.61 (−2.29, 0.77) 1 12.50 (12.50, 12.50) −2.80 (− 2.80,-2.80) NS
Stigma
Mothers 42 1.60 (1.00. 2.67) −0.25 (−1.21, 1.44) 35 1.40 (1.00, 3.20) −0.57 (−1.21, 2.29) NS
Fathers 13 1.40 (1.00, 2.10) −0.36 (−1.27, 1.23) 9 1.60 (1.00, 2.11) 0.09 (−1.27, 1.25) NS
PHQ-4
Mothers 40 1.00 (0.00, 8.00) 0.54 (0.89, 1.96) 34 0.00 (0.00, 6.00) 0.89 (−1.25, 0.89) NS
Fathers 12 0.00 (0.00, 6.00) 0.89 (0.89, 1.25) 9 0.00 (0.00, 4.00) 0.89 (−0.54, 0.89) NS
an’s vary by domain due to item responses and not all children have had surgery or take medication. bSDS standard deviation score; subscale values are
presented as SDS based on reference data. cp values have been adjusted for multiple comparisons using false discovery rates; significance has been assigned at
adjusted p < 0.05. *p < 0.05, compared to SDS of zero. All p values have been adjusted for multiple comparisons
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In the future, it will also be valuable to obtain longitu-
dinal data to assess the responsiveness of the question-
naire by observing the temporal variation in outcomes in
children with an assessment of factors (e.g. psychology
services, timing of surgical interventions) that may influ-
ence a change in reported adaptation over time.
The questionnaires were designed for parents of chil-
dren under the age of 7 years, thus, there is a need to de-
velop similar tools for older children and adults.
Furthermore, the questionnaires were developed in the
English language, thus, lack of availability of the ques-
tionnaires in other languages may have provided a
Fig. 2 Boxplots for Future Concerns, Clinic Visits and Depression. DSD, Disorder of Sex Development; Endocrine, Children with other Endocrine
conditions. *p < 0.05 represents a significant difference compared to zero
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barrier for completion for some parents. The translation
of questionnaires into other languages and their valid-
ation in different countries will need to be addressed in
the future [31]. Nevertheless, the use of this quick and
practical tool in the routine clinic setting raised some
important and noteworthy observations.
Compared with parents of children with other Endo-
crine conditions, parents of children with DSD reported
greater Future Concerns with regards to their child’s
condition. These results highlight the need for ongoing
parental support and effective communication between
the multidisciplinary team and families [32] and the
provision of early psychological input for parents of
young children with DSD [12]. Despite these greater
anxieties, fathers of children with DSD reported less
stress with regards to attending for Clinic Visits and ad-
ministering and managing Medication required for their
child’s condition. It is commonly the case that mothers
and fathers have different perceptions with regards to
their child’s medical condition and perceive their child’s
behaviour and emotions differently [33, 34]. It is unclear
whether these differences are exaggerated in the context
of DSD and our preliminary findings need to be con-
firmed in a larger sample size with a broad spectrum of
DSD diagnoses. Approximately a quarter of cases of
DSD are associated with multisystem co-morbidity [35];
similarly, in our current cohort, a third of children with
DSD had other co-existing chronic conditions and the
contribution of these co-morbidities to psychosocial
well-being is not well established.
Parents of children with DSD and other Endocrine
conditions reported more Depression compared to refer-
ence data; however, our results did not show any signifi-
cant difference for any of the four PROMIS® domains
(Anger, Anxiety, Depressive symptoms and Peer relation-
ships) between parents of children with DSD and parents
of children with other Endocrine conditions. Interestingly,
for many domains including Healthcare Communication
& Information and Stigma, scores were similar for parents
of children with DSD and other Endocrine conditions,
perhaps implying that parents of children with DSD have
more positive experiences than anecdotal experience may
suggest. Whilst there was no significant difference in the
number of Missed School Days between DSD and Endo-
crine samples, this was an important domain for inclusion
as previous studies have shown that children with chronic
health conditions have greater school absenteeism and
lower academic achievement than children who do not
have chronic conditions [36, 37].
In summary, we have demonstrated that brief ques-
tionnaires are useful tools for collecting parent-reported
psychosocial data for young children with DSD. The pat-
terns of parental reporting observed can not only im-
prove targeting of resources, but may also enable a
greater understanding of the effect of the child’s condi-
tion on individual carers. A combination of generic and
condition-specific scales may be more helpful than gen-
eric scales alone for identifying particular issues that
need to be addressed in children with DSD and their
families. Nevertheless, measures of cross-cutting do-
mains (e.g., emotional state, behaviour problems, peer
relations, etc) remain critically important because behav-
iour in these areas provide sine qua non evidence of
adaptive or impaired psychological function. As such,
scores on these latter measures can be used to compare
adaptation and the influence of care strategies across
specific DSD populations and against patients with other
chronic paediatric conditions. Aggregating such data
Table 4 Parent Proxy-Report questionnaire scores for children with DSD and children with other Endocrine conditions
Proxy-Report Domains DSD Sample Endocrine Sample DSD vs Endocrine
na Subscale scoreb,
median (range)
SDSc, median (range) na Subscale scoreb,
median (range)
SDS, median (range) p valued
Anxiety 23 43.60 (36.30, 68.60) 0.64 (−1.86, 1.37) 21 46.00 (36.30, 75.30) 0.40 (−2.53, 1.37) NS
Depression 23 37.20 (37.20, 65.20) 1.28* (−1.52, 1.28) 22 43.60 (37.20, 60.10) 0.64* (−1.01, 1.28) NS
Anger 23 43.40 (29.00, 62.70) 0.66 (−1.27, 2.10) 22 42.50 (29.00, 67.70) 0.75 (−1.77, 2.10) NS
Peer Relations 23 50.60 (27.30, 60.80) 0.06 (−2.27, 1.08) 22 48.25 (19.10, 60.80) −0.18 (−3.09, 1.08) NS
Stigma
Mothers 17 1.33 (1.00, 4.00) −1.04 (−1.41, 1.89) 16 1.70 (1.00, 4.25) −0.63 (−1.41, 2.17) NS
Fathers 6 1.13 (1.00, 3.00) −1.14 (− 1.30, 1.17) 6 1.75 (1.00, 2.50) −0.37 (− 1.30, 0.56) NS
Clinic Visit/ Medication NS
Mothers 16 81.67 (3.33, 100.00) 0.68 (−2.52, 1.43) 17 93.30 (54.17, 100.00) 1.16 (−2.65, 1.43) NS
Fathers 6 75.00 (40.00, 83.33) −0.14 (−1.69, 0.23) 6 87.50 (66.67, 100.00) 0.42 (−0.51, 0.97) NS
an’s vary by domain due to item responses and not all children take medication. bFor anxiety, depression, anger and peer relations, the subscale score represents
the PROMIS T-score. cSDS standard deviation score, calculated using mean and SD from reference data. dp values have been adjusted for multiple comparisons
using false discovery rates; significance has been assigned at adjusted p < 0.05. *p < 0.05, compared to SDS of zero. All p values have been adjusted for
multiple comparisons
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longitudinally and across multiple centres will create the
opportunity for developing robust reference data which
can be employed as clinical benchmarks [38] useful in
guiding a process of continuous quality improvement in
the care of these patients and their families.
Conclusions
We present the first study reporting on the use of brief
Parent Self-Report and Parent Proxy-Report question-
naires in a routine clinic setting for parents of young
children with DSD. Preliminary results demonstrate that
the screening approach followed is both feasible in the
clinical context and acceptable to patients. Further,
questionnaire scores showed variability across families
and diagnostic categories; item responses suggested im-
mediately actionable opportunities for counselling and
clinical intervention. A broad consensus exists in the
medical community regarding the influence of psycho-
social aspects of DSD on patient and family outcomes.
This report demonstrates that clinicians caring for these
patients and their families can employ simple tools to
identify psychosocial problems and tailor clinical recom-
mendations accordingly.
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